A Qualitative Exploration into the Experience of Neuroendocrine Pancreatic Cancer Patients Receiving Molecular Targeted Therapies

#1667

Introduction: Despite extensive efficacy date and limited data examining drug related side effects, the patient experience and quality of life data is limited for this patient group

Aim(s): The focus of this research is to explore the patient experience of receiving Sunitinib and Everolimus. It aims to explore the true lived experience of receiving molecular targeted agents

Materials and methods: A Qualitative approach was adopted using Phenomenological enquiry, interviews

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Quaglia E

Authors: Quaglia E, Uzzell M, Woodcock J, Caplin M,

Keywords: Sunitinib, everolimus,